| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ubiquitin-Activating Enzymes | 2 | 2023 | 83 | 1.000 |
Why?
|
| Co-Repressor Proteins | 3 | 2018 | 194 | 0.740 |
Why?
|
| Genes, Tumor Suppressor | 4 | 2016 | 1097 | 0.720 |
Why?
|
| Leukemia, Myeloid | 3 | 2016 | 707 | 0.690 |
Why?
|
| Repressor Proteins | 4 | 2018 | 3023 | 0.640 |
Why?
|
| Spasms, Infantile | 1 | 2021 | 305 | 0.600 |
Why?
|
| Homocystinuria | 1 | 2016 | 67 | 0.560 |
Why?
|
| Abnormalities, Multiple | 4 | 2019 | 1416 | 0.540 |
Why?
|
| Myopia | 1 | 2016 | 254 | 0.470 |
Why?
|
| Microcephaly | 4 | 2023 | 432 | 0.470 |
Why?
|
| Mutation, Missense | 10 | 2024 | 2564 | 0.440 |
Why?
|
| Guanine Nucleotide Exchange Factors | 1 | 2016 | 581 | 0.420 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2016 | 372 | 0.420 |
Why?
|
| Wnt Proteins | 1 | 2016 | 721 | 0.420 |
Why?
|
| NF-kappa B | 2 | 2022 | 2499 | 0.410 |
Why?
|
| Phenotype | 15 | 2023 | 16365 | 0.390 |
Why?
|
| Bone Development | 1 | 2014 | 483 | 0.380 |
Why?
|
| Muscle Hypotonia | 4 | 2021 | 165 | 0.380 |
Why?
|
| Core Binding Factor Alpha 2 Subunit | 2 | 2013 | 345 | 0.360 |
Why?
|
| Chromosomes, Human, Pair 9 | 2 | 2016 | 535 | 0.350 |
Why?
|
| Stromal Cells | 1 | 2014 | 1355 | 0.330 |
Why?
|
| Gene Deletion | 5 | 2019 | 2751 | 0.310 |
Why?
|
| Nuclear Proteins | 2 | 2016 | 5853 | 0.310 |
Why?
|
| Inflammation | 3 | 2022 | 10638 | 0.290 |
Why?
|
| Chromosome Deletion | 2 | 2016 | 1401 | 0.290 |
Why?
|
| Hematopoietic Stem Cells | 3 | 2014 | 3386 | 0.260 |
Why?
|
| Leukemia, Myeloid, Acute | 6 | 2013 | 3523 | 0.250 |
Why?
|
| Carrier Proteins | 9 | 2021 | 5021 | 0.250 |
Why?
|
| Hematopoiesis | 1 | 2014 | 2072 | 0.250 |
Why?
|
| Oncogene Proteins, Fusion | 2 | 2013 | 1581 | 0.240 |
Why?
|
| Mutation | 12 | 2022 | 29786 | 0.230 |
Why?
|
| Brain Diseases | 2 | 2023 | 1563 | 0.230 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2024 | 95 | 0.220 |
Why?
|
| beta Catenin | 3 | 2020 | 1059 | 0.220 |
Why?
|
| Nerve Tissue Proteins | 8 | 2021 | 4462 | 0.220 |
Why?
|
| Myeloid Cells | 1 | 2008 | 810 | 0.220 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2022 | 52 | 0.210 |
Why?
|
| Phosphatidylinositols | 1 | 2023 | 291 | 0.210 |
Why?
|
| Movement Disorders | 2 | 2023 | 445 | 0.210 |
Why?
|
| Hereditary Autoinflammatory Diseases | 1 | 2022 | 39 | 0.210 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 5 | 2003 | 1660 | 0.200 |
Why?
|
| Leigh Disease | 1 | 2022 | 75 | 0.200 |
Why?
|
| Hereditary Sensory and Autonomic Neuropathies | 1 | 2021 | 40 | 0.190 |
Why?
|
| Facies | 2 | 2019 | 197 | 0.190 |
Why?
|
| F-Box Proteins | 2 | 2019 | 197 | 0.190 |
Why?
|
| Mitochondrial Diseases | 2 | 2014 | 320 | 0.190 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2016 | 2849 | 0.190 |
Why?
|
| Nervous System Malformations | 1 | 2022 | 247 | 0.180 |
Why?
|
| Urea Cycle Disorders, Inborn | 1 | 2020 | 31 | 0.180 |
Why?
|
| Tristetraprolin | 1 | 2020 | 42 | 0.180 |
Why?
|
| Heterozygote | 5 | 2022 | 2804 | 0.180 |
Why?
|
| Hyperammonemia | 1 | 2020 | 76 | 0.180 |
Why?
|
| Neoplasm Proteins | 7 | 1989 | 3703 | 0.170 |
Why?
|
| RNA Processing, Post-Transcriptional | 2 | 2020 | 436 | 0.170 |
Why?
|
| Multiple Endocrine Neoplasia Type 2a | 1 | 1999 | 44 | 0.170 |
Why?
|
| Mitochondrial Membrane Transport Proteins | 1 | 2020 | 154 | 0.170 |
Why?
|
| Loss of Heterozygosity | 1 | 2001 | 684 | 0.170 |
Why?
|
| Hyperventilation | 1 | 2019 | 81 | 0.170 |
Why?
|
| DNA-Directed RNA Polymerases | 2 | 2014 | 371 | 0.170 |
Why?
|
| Ganglioneuroma | 1 | 1999 | 57 | 0.170 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2019 | 89 | 0.170 |
Why?
|
| Retinitis Pigmentosa | 1 | 2022 | 386 | 0.160 |
Why?
|
| Genes | 7 | 1988 | 1893 | 0.160 |
Why?
|
| Drosophila | 5 | 2024 | 1491 | 0.160 |
Why?
|
| Protein-Arginine N-Methyltransferases | 1 | 2019 | 131 | 0.160 |
Why?
|
| Genetic Testing | 5 | 2019 | 3444 | 0.160 |
Why?
|
| Growth Hormone | 3 | 1989 | 705 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 315 | 0.150 |
Why?
|
| Epilepsy | 4 | 2021 | 3310 | 0.150 |
Why?
|
| Nephrosis | 1 | 2017 | 45 | 0.150 |
Why?
|
| Mice, Transgenic | 11 | 2016 | 9734 | 0.150 |
Why?
|
| Leukoencephalopathies | 1 | 2020 | 238 | 0.150 |
Why?
|
| Jaw Abnormalities | 1 | 2016 | 27 | 0.150 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 2016 | 371 | 0.150 |
Why?
|
| Ataxia | 2 | 2020 | 304 | 0.140 |
Why?
|
| Heart Murmurs | 1 | 2016 | 94 | 0.140 |
Why?
|
| Hernia, Hiatal | 1 | 2017 | 79 | 0.140 |
Why?
|
| Phenylalanine-tRNA Ligase | 1 | 2016 | 16 | 0.140 |
Why?
|
| Drosophila Proteins | 3 | 2023 | 1703 | 0.140 |
Why?
|
| Cloning, Molecular | 6 | 1988 | 4320 | 0.140 |
Why?
|
| Child | 19 | 2024 | 77709 | 0.140 |
Why?
|
| Genetic Association Studies | 3 | 2021 | 2703 | 0.140 |
Why?
|
| Sympathetic Nervous System | 1 | 1999 | 514 | 0.140 |
Why?
|
| Developmental Disabilities | 2 | 2024 | 1456 | 0.140 |
Why?
|
| Adenosine Triphosphatases | 1 | 2020 | 839 | 0.140 |
Why?
|
| Funnel Chest | 1 | 2016 | 71 | 0.140 |
Why?
|
| Epilepsy, Generalized | 1 | 2018 | 174 | 0.130 |
Why?
|
| Cerebellar Diseases | 1 | 2018 | 226 | 0.130 |
Why?
|
| Behavior | 1 | 2019 | 561 | 0.130 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2016 | 80 | 0.130 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2019 | 670 | 0.130 |
Why?
|
| Gene Expression Regulation, Leukemic | 2 | 2016 | 651 | 0.130 |
Why?
|
| Vesicular Transport Proteins | 1 | 2018 | 377 | 0.130 |
Why?
|
| Growth Disorders | 1 | 2020 | 645 | 0.130 |
Why?
|
| Protein Kinases | 1 | 2022 | 1640 | 0.130 |
Why?
|
| Mandibulofacial Dysostosis | 1 | 2014 | 34 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2008 | 460 | 0.130 |
Why?
|
| Syndrome | 5 | 2023 | 3251 | 0.130 |
Why?
|
| Zebrafish Proteins | 3 | 2017 | 1005 | 0.130 |
Why?
|
| Klippel-Feil Syndrome | 1 | 2014 | 19 | 0.130 |
Why?
|
| Drosophila melanogaster | 1 | 2023 | 1708 | 0.120 |
Why?
|
| Humans | 59 | 2024 | 744343 | 0.120 |
Why?
|
| Animals | 32 | 2024 | 168757 | 0.120 |
Why?
|
| Rare Diseases | 1 | 2018 | 553 | 0.120 |
Why?
|
| Nuclear Family | 1 | 2014 | 318 | 0.110 |
Why?
|
| Chromosome Segregation | 1 | 2014 | 235 | 0.110 |
Why?
|
| Homocysteine | 1 | 2016 | 647 | 0.110 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1999 | 740 | 0.110 |
Why?
|
| Ubiquinone | 1 | 2014 | 188 | 0.110 |
Why?
|
| Histones | 1 | 2023 | 2599 | 0.110 |
Why?
|
| Receptors, GABA-A | 1 | 2017 | 627 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2001 | 4554 | 0.110 |
Why?
|
| Neurons | 3 | 2023 | 9338 | 0.110 |
Why?
|
| ras Proteins | 1 | 1997 | 1060 | 0.110 |
Why?
|
| Intestine, Small | 3 | 1988 | 1241 | 0.100 |
Why?
|
| Child, Preschool | 14 | 2021 | 41006 | 0.100 |
Why?
|
| Neoplastic Stem Cells | 2 | 2013 | 1376 | 0.100 |
Why?
|
| Fathers | 1 | 2014 | 358 | 0.100 |
Why?
|
| HEK293 Cells | 1 | 2021 | 4204 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2023 | 2133 | 0.100 |
Why?
|
| Muscle Weakness | 1 | 2014 | 413 | 0.100 |
Why?
|
| Adolescent | 13 | 2021 | 85781 | 0.100 |
Why?
|
| Zebrafish | 5 | 2023 | 2994 | 0.100 |
Why?
|
| Microsatellite Repeats | 2 | 2005 | 802 | 0.100 |
Why?
|
| Mice | 19 | 2022 | 81183 | 0.100 |
Why?
|
| Translocation, Genetic | 2 | 2008 | 1420 | 0.100 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 1119 | 0.100 |
Why?
|
| DNA-Binding Proteins | 2 | 2008 | 9648 | 0.100 |
Why?
|
| Cyclooxygenase 2 | 1 | 2013 | 611 | 0.090 |
Why?
|
| Cell Lineage | 2 | 2018 | 2504 | 0.090 |
Why?
|
| Proteins | 3 | 2022 | 6103 | 0.090 |
Why?
|
| Fatty Acid-Binding Proteins | 7 | 1989 | 300 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 996 | 0.090 |
Why?
|
| Nervous System Diseases | 1 | 2020 | 1622 | 0.090 |
Why?
|
| Genetic Linkage | 5 | 1996 | 2421 | 0.090 |
Why?
|
| Medical Informatics | 1 | 2016 | 745 | 0.080 |
Why?
|
| Eye Diseases | 1 | 2014 | 669 | 0.080 |
Why?
|
| Male | 22 | 2021 | 350118 | 0.080 |
Why?
|
| DNA, Complementary | 2 | 2022 | 2050 | 0.080 |
Why?
|
| K562 Cells | 3 | 2020 | 634 | 0.080 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2014 | 612 | 0.080 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 3597 | 0.080 |
Why?
|
| Age of Onset | 3 | 2020 | 3271 | 0.080 |
Why?
|
| Cell Proliferation | 3 | 2023 | 10481 | 0.080 |
Why?
|
| Immunity | 1 | 2014 | 1012 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 1 | 2016 | 6314 | 0.080 |
Why?
|
| Transcription Factors | 5 | 2024 | 12208 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2018 | 4803 | 0.080 |
Why?
|
| Receptors, Endothelin | 2 | 2000 | 58 | 0.080 |
Why?
|
| Female | 24 | 2023 | 380194 | 0.080 |
Why?
|
| Insurance Coverage | 1 | 2019 | 1901 | 0.080 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 12959 | 0.080 |
Why?
|
| Sphingomyelin Phosphodiesterase | 1 | 2008 | 91 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 21 | 1 | 2008 | 230 | 0.080 |
Why?
|
| ACTH Syndrome, Ectopic | 1 | 2007 | 30 | 0.080 |
Why?
|
| Adrenal Glands | 3 | 1999 | 546 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1997 | 2942 | 0.080 |
Why?
|
| Cohort Studies | 4 | 2022 | 40561 | 0.070 |
Why?
|
| Lumbar Vertebrae | 1 | 2016 | 1848 | 0.070 |
Why?
|
| Neoplasms, Complex and Mixed | 1 | 2007 | 31 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2023 | 5708 | 0.070 |
Why?
|
| Hyperplasia | 3 | 1999 | 1185 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2016 | 1861 | 0.070 |
Why?
|
| MicroRNAs | 1 | 2023 | 3752 | 0.070 |
Why?
|
| Ceramides | 1 | 2008 | 199 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 4 | 1 | 1987 | 374 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 1987 | 326 | 0.070 |
Why?
|
| Genetic Variation | 2 | 2019 | 6544 | 0.070 |
Why?
|
| Bone Marrow Cells | 1 | 2014 | 2513 | 0.070 |
Why?
|
| Kidney | 2 | 1999 | 7186 | 0.070 |
Why?
|
| Hirschsprung Disease | 2 | 2000 | 155 | 0.070 |
Why?
|
| RNA Polymerase II | 2 | 1987 | 551 | 0.070 |
Why?
|
| Pedigree | 3 | 2021 | 4644 | 0.070 |
Why?
|
| Infant | 8 | 2021 | 35136 | 0.070 |
Why?
|
| DNA Methylation | 1 | 2019 | 4286 | 0.070 |
Why?
|
| Cushing Syndrome | 1 | 2007 | 249 | 0.060 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2007 | 648 | 0.060 |
Why?
|
| Anxiety | 1 | 2019 | 4297 | 0.060 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2020 | 5172 | 0.060 |
Why?
|
| fms-Like Tyrosine Kinase 3 | 2 | 2006 | 491 | 0.060 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1988 | 794 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2018 | 4479 | 0.060 |
Why?
|
| Oncogene Proteins | 1 | 2009 | 749 | 0.060 |
Why?
|
| Embryo, Nonmammalian | 1 | 2008 | 895 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2005 | 403 | 0.060 |
Why?
|
| Dopamine beta-Hydroxylase | 3 | 1999 | 75 | 0.060 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group C | 1 | 2023 | 14 | 0.060 |
Why?
|
| Gene Expression Regulation | 3 | 2009 | 12072 | 0.060 |
Why?
|
| Bone Density | 1 | 2016 | 3468 | 0.060 |
Why?
|
| Young Adult | 5 | 2021 | 56430 | 0.060 |
Why?
|
| Leukocyte Count | 3 | 2003 | 1588 | 0.060 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2023 | 70 | 0.060 |
Why?
|
| Base Sequence | 11 | 2008 | 12797 | 0.050 |
Why?
|
| Phosphatidylinositol Phosphates | 1 | 2023 | 209 | 0.050 |
Why?
|
| Serum Amyloid A Protein | 1 | 2022 | 121 | 0.050 |
Why?
|
| Cell Death | 1 | 2008 | 1706 | 0.050 |
Why?
|
| Protein Conformation | 3 | 2021 | 4011 | 0.050 |
Why?
|
| Software | 1 | 2016 | 4443 | 0.050 |
Why?
|
| Haploinsufficiency | 1 | 2023 | 328 | 0.050 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2020 | 17446 | 0.050 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2023 | 431 | 0.050 |
Why?
|
| Escherichia coli | 4 | 1988 | 4217 | 0.050 |
Why?
|
| DNA Primers | 1 | 2005 | 2892 | 0.050 |
Why?
|
| Cell Survival | 2 | 2008 | 5882 | 0.050 |
Why?
|
| Liver | 7 | 1996 | 7474 | 0.050 |
Why?
|
| Infant, Newborn | 5 | 2019 | 25625 | 0.050 |
Why?
|
| Cytogenetic Analysis | 1 | 2001 | 295 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-ret | 2 | 1999 | 220 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 6 | 2020 | 21827 | 0.050 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2020 | 38 | 0.050 |
Why?
|
| Piebaldism | 1 | 2000 | 3 | 0.050 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2020 | 44 | 0.050 |
Why?
|
| Endothelin-3 | 1 | 2000 | 8 | 0.050 |
Why?
|
| Genomics | 1 | 2016 | 5720 | 0.050 |
Why?
|
| Multiple Endocrine Neoplasia Type 2b | 1 | 1999 | 10 | 0.050 |
Why?
|
| Reflex, Abnormal | 1 | 2020 | 84 | 0.050 |
Why?
|
| DNA Restriction Enzymes | 4 | 1987 | 570 | 0.050 |
Why?
|
| Genes, ras | 1 | 2003 | 690 | 0.050 |
Why?
|
| Amino Acid Sequence | 11 | 1988 | 13815 | 0.050 |
Why?
|
| Transcription, Genetic | 5 | 1987 | 7722 | 0.040 |
Why?
|
| Heat-Shock Proteins | 3 | 1988 | 822 | 0.040 |
Why?
|
| Disease Susceptibility | 2 | 2019 | 1782 | 0.040 |
Why?
|
| Leukemia | 1 | 2008 | 1511 | 0.040 |
Why?
|
| Ammonia | 1 | 2020 | 239 | 0.040 |
Why?
|
| Mice, Knockout | 1 | 2014 | 14557 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 15540 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 2 | 1987 | 2752 | 0.040 |
Why?
|
| Models, Molecular | 2 | 2021 | 5456 | 0.040 |
Why?
|
| Immunophenotyping | 1 | 2023 | 1880 | 0.040 |
Why?
|
| Zinc | 1 | 2023 | 684 | 0.040 |
Why?
|
| Hep G2 Cells | 1 | 2020 | 393 | 0.040 |
Why?
|
| Muscle, Smooth | 1 | 2023 | 934 | 0.040 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2023 | 687 | 0.040 |
Why?
|
| Mycobacterium leprae | 2 | 1988 | 94 | 0.040 |
Why?
|
| Interneurons | 1 | 2023 | 577 | 0.040 |
Why?
|
| Core Binding Factor Alpha 3 Subunit | 1 | 2018 | 56 | 0.040 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2019 | 182 | 0.040 |
Why?
|
| Karyotyping | 2 | 1997 | 1243 | 0.040 |
Why?
|
| Cysteine | 1 | 2023 | 874 | 0.040 |
Why?
|
| Mammals | 1 | 2024 | 1143 | 0.040 |
Why?
|
| Intestinal Mucosa | 2 | 1989 | 3036 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2020 | 2915 | 0.040 |
Why?
|
| Mitochondria | 2 | 2022 | 3520 | 0.040 |
Why?
|
| Urea | 1 | 2020 | 450 | 0.040 |
Why?
|
| Adrenal Medulla | 1 | 1997 | 58 | 0.040 |
Why?
|
| Delivery of Health Care | 1 | 2016 | 5319 | 0.040 |
Why?
|
| Peripheral Nervous System Neoplasms | 1 | 1999 | 122 | 0.040 |
Why?
|
| Signal Transduction | 4 | 2013 | 23403 | 0.040 |
Why?
|
| Ganglia, Sympathetic | 1 | 1997 | 62 | 0.040 |
Why?
|
| Alternative Splicing | 1 | 2023 | 1117 | 0.040 |
Why?
|
| DNA | 3 | 1986 | 7301 | 0.040 |
Why?
|
| DNA Helicases | 1 | 2023 | 859 | 0.040 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 1 | 1999 | 494 | 0.040 |
Why?
|
| Fatal Outcome | 2 | 2016 | 1850 | 0.040 |
Why?
|
| Acute Disease | 2 | 2005 | 7149 | 0.040 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 1987 | 1888 | 0.040 |
Why?
|
| Genes, Bacterial | 4 | 1988 | 1079 | 0.040 |
Why?
|
| Family | 2 | 2021 | 3147 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2022 | 1152 | 0.040 |
Why?
|
| Retinol-Binding Proteins | 2 | 1987 | 65 | 0.040 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 697 | 0.040 |
Why?
|
| Dystonia | 1 | 2020 | 363 | 0.040 |
Why?
|
| Nerve Growth Factors | 1 | 1999 | 574 | 0.040 |
Why?
|
| Genes, myc | 1 | 1997 | 399 | 0.030 |
Why?
|
| DNA Mutational Analysis | 3 | 2014 | 4186 | 0.030 |
Why?
|
| RNA, Messenger | 5 | 1997 | 13033 | 0.030 |
Why?
|
| Germ Cells | 1 | 2020 | 631 | 0.030 |
Why?
|
| Speech Disorders | 1 | 2017 | 189 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2023 | 1349 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 396 | 0.030 |
Why?
|
| Neurites | 1 | 1997 | 388 | 0.030 |
Why?
|
| Actins | 1 | 2023 | 2121 | 0.030 |
Why?
|
| Amyloidosis | 1 | 2022 | 795 | 0.030 |
Why?
|
| Cells, Cultured | 2 | 2023 | 19229 | 0.030 |
Why?
|
| Epithelium | 3 | 1989 | 1679 | 0.030 |
Why?
|
| Protein Binding | 1 | 2008 | 9386 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2020 | 587 | 0.030 |
Why?
|
| CpG Islands | 1 | 2019 | 1172 | 0.030 |
Why?
|
| Mice, Inbred Strains | 1 | 1997 | 1827 | 0.030 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2018 | 780 | 0.030 |
Why?
|
| RNA, Transfer | 1 | 2017 | 316 | 0.030 |
Why?
|
| Chromosome Disorders | 1 | 1997 | 514 | 0.030 |
Why?
|
| Hominidae | 1 | 1995 | 74 | 0.030 |
Why?
|
| Brain | 1 | 2021 | 26385 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 809 | 0.030 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2014 | 78 | 0.030 |
Why?
|
| Aneuploidy | 1 | 1997 | 530 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1995 | 380 | 0.030 |
Why?
|
| Nephrotic Syndrome | 1 | 2017 | 389 | 0.030 |
Why?
|
| Amino Acid Metabolism, Inborn Errors | 1 | 1996 | 255 | 0.030 |
Why?
|
| Podocytes | 1 | 2017 | 396 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 2014 | 315 | 0.030 |
Why?
|
| Kidney Calices | 1 | 1993 | 26 | 0.030 |
Why?
|
| Genes, Dominant | 1 | 1996 | 880 | 0.030 |
Why?
|
| Chromosome Mapping | 2 | 1995 | 4740 | 0.030 |
Why?
|
| Genetic Markers | 1 | 2019 | 2634 | 0.030 |
Why?
|
| RNA-Binding Proteins | 1 | 2022 | 1903 | 0.030 |
Why?
|
| Tandem Repeat Sequences | 2 | 2006 | 185 | 0.030 |
Why?
|
| Species Specificity | 2 | 1987 | 2478 | 0.030 |
Why?
|
| Antigens, Bacterial | 2 | 1988 | 1171 | 0.030 |
Why?
|
| Glycine | 1 | 1996 | 671 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2017 | 1185 | 0.030 |
Why?
|
| Nucleic Acid Hybridization | 3 | 1988 | 1375 | 0.030 |
Why?
|
| Melanocytes | 1 | 1995 | 515 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1988 | 1085 | 0.030 |
Why?
|
| Models, Animal | 1 | 2018 | 2171 | 0.030 |
Why?
|
| Cell Cycle Proteins | 1 | 2023 | 3462 | 0.020 |
Why?
|
| Workflow | 1 | 2016 | 847 | 0.020 |
Why?
|
| Sulfonamides | 2 | 2013 | 1938 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2020 | 2967 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 16689 | 0.020 |
Why?
|
| Restriction Mapping | 2 | 1988 | 878 | 0.020 |
Why?
|
| Chromosome Aberrations | 1 | 1997 | 1813 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2001 | 5974 | 0.020 |
Why?
|
| Reimbursement Mechanisms | 1 | 2016 | 670 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 3 | 1987 | 798 | 0.020 |
Why?
|
| Proteome | 1 | 2020 | 1799 | 0.020 |
Why?
|
| Retina | 1 | 2020 | 2616 | 0.020 |
Why?
|
| Neuroblastoma | 1 | 1997 | 1226 | 0.020 |
Why?
|
| Pancreatic Neoplasms | 1 | 2007 | 5256 | 0.020 |
Why?
|
| Nitrobenzenes | 1 | 2009 | 65 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2013 | 2085 | 0.020 |
Why?
|
| Molecular Sequence Data | 5 | 1988 | 18111 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 2 | 2000 | 438 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 2 | 1989 | 1799 | 0.020 |
Why?
|
| Intestines | 2 | 1989 | 1924 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2020 | 4420 | 0.020 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2013 | 1213 | 0.020 |
Why?
|
| Rats, Inbred Strains | 2 | 1986 | 2186 | 0.020 |
Why?
|
| Disease Management | 1 | 2019 | 2459 | 0.020 |
Why?
|
| Leprosy | 1 | 1988 | 124 | 0.020 |
Why?
|
| Radioimmunoassay | 1 | 1988 | 919 | 0.020 |
Why?
|
| DNA Repair | 1 | 2017 | 2046 | 0.020 |
Why?
|
| Cell Differentiation | 3 | 2009 | 11483 | 0.020 |
Why?
|
| Adult | 5 | 2020 | 214055 | 0.020 |
Why?
|
| Seizures | 1 | 2020 | 2859 | 0.020 |
Why?
|
| Research | 1 | 2016 | 1999 | 0.020 |
Why?
|
| Prognosis | 3 | 2006 | 29063 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2020 | 10252 | 0.020 |
Why?
|
| Mycobacterium tuberculosis | 2 | 1988 | 1832 | 0.020 |
Why?
|
| Genotype | 3 | 2014 | 12951 | 0.020 |
Why?
|
| Bacteriophage lambda | 1 | 1987 | 147 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2019 | 8642 | 0.020 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2006 | 118 | 0.020 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1988 | 416 | 0.020 |
Why?
|
| Epigenesis, Genetic | 1 | 2019 | 3647 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 1989 | 2327 | 0.020 |
Why?
|
| Colony-Forming Units Assay | 1 | 2006 | 356 | 0.020 |
Why?
|
| Dinoprostone | 1 | 2009 | 600 | 0.020 |
Why?
|
| Peptide Chain Initiation, Translational | 1 | 1986 | 103 | 0.020 |
Why?
|
| Mosaicism | 1 | 1988 | 441 | 0.020 |
Why?
|
| Erythroid Precursor Cells | 1 | 2006 | 218 | 0.020 |
Why?
|
| Eukaryotic Cells | 1 | 1987 | 198 | 0.020 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2018 | 4386 | 0.020 |
Why?
|
| Membrane Proteins | 1 | 2022 | 7880 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2020 | 77449 | 0.020 |
Why?
|
| Genes, Fungal | 1 | 1987 | 455 | 0.020 |
Why?
|
| Enzymes | 1 | 1987 | 266 | 0.020 |
Why?
|
| Cell Movement | 1 | 2017 | 5217 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1988 | 1682 | 0.020 |
Why?
|
| Health Care Costs | 1 | 2018 | 3209 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2013 | 2382 | 0.020 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2006 | 294 | 0.020 |
Why?
|
| Macromolecular Substances | 1 | 1987 | 1454 | 0.020 |
Why?
|
| Antigens, CD34 | 1 | 2006 | 657 | 0.020 |
Why?
|
| Animals, Genetically Modified | 1 | 2009 | 1549 | 0.010 |
Why?
|
| Organ Specificity | 1 | 1988 | 2008 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2014 | 2759 | 0.010 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2008 | 783 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2008 | 1526 | 0.010 |
Why?
|
| Referral and Consultation | 1 | 2016 | 3528 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1987 | 912 | 0.010 |
Why?
|
| Small Molecule Libraries | 1 | 2009 | 720 | 0.010 |
Why?
|
| Pregnancy | 2 | 2023 | 29144 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2014 | 4560 | 0.010 |
Why?
|
| Computational Biology | 1 | 2014 | 3521 | 0.010 |
Why?
|
| Osteosarcoma | 1 | 2008 | 881 | 0.010 |
Why?
|
| Recurrence | 1 | 2014 | 8340 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 2 | 1996 | 5867 | 0.010 |
Why?
|
| Prevalence | 2 | 2014 | 15226 | 0.010 |
Why?
|
| Age Factors | 1 | 2019 | 18370 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1999 | 11366 | 0.010 |
Why?
|
| United States | 2 | 2019 | 69872 | 0.010 |
Why?
|
| Apoptosis | 1 | 2017 | 9727 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2019 | 21746 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 12804 | 0.010 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor Receptors | 1 | 1999 | 13 | 0.010 |
Why?
|
| Middle Aged | 3 | 2020 | 213383 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 25043 | 0.010 |
Why?
|
| Lymphocytes | 2 | 2001 | 2617 | 0.010 |
Why?
|
| Rats | 5 | 1989 | 24260 | 0.010 |
Why?
|
| SOXE Transcription Factors | 1 | 1999 | 57 | 0.010 |
Why?
|
| Glial Cell Line-Derived Neurotrophic Factor | 1 | 1999 | 65 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14722 | 0.010 |
Why?
|
| High Mobility Group Proteins | 1 | 1999 | 187 | 0.010 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2008 | 1519 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 2 | 2001 | 6171 | 0.010 |
Why?
|
| Fatty Acids | 1 | 1987 | 1809 | 0.010 |
Why?
|
| RNA | 1 | 1988 | 2749 | 0.010 |
Why?
|
| Remission Induction | 1 | 2003 | 2386 | 0.010 |
Why?
|
| Retinol-Binding Proteins, Cellular | 2 | 1987 | 13 | 0.010 |
Why?
|
| Organ Culture Techniques | 1 | 1999 | 813 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2014 | 63114 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2014 | 19905 | 0.010 |
Why?
|
| Nervous System | 1 | 2000 | 554 | 0.010 |
Why?
|
| Transplantation Conditioning | 1 | 2003 | 1598 | 0.010 |
Why?
|
| Antigens, CD | 1 | 2006 | 4026 | 0.010 |
Why?
|
| Tuberculosis | 1 | 1988 | 1912 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2014 | 15519 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 163280 | 0.010 |
Why?
|
| Alleles | 1 | 2006 | 6933 | 0.010 |
Why?
|
| Bone Marrow Transplantation | 1 | 2003 | 2765 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1995 | 366 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2021 | 35421 | 0.010 |
Why?
|
| Neural Crest | 1 | 1996 | 275 | 0.010 |
Why?
|
| Myocardium | 1 | 1987 | 4776 | 0.010 |
Why?
|
| Vagus Nerve | 1 | 1996 | 438 | 0.010 |
Why?
|
| Enteric Nervous System | 1 | 1995 | 189 | 0.010 |
Why?
|
| Mice, Mutant Strains | 1 | 1996 | 1866 | 0.010 |
Why?
|
| Disease-Free Survival | 1 | 2003 | 6895 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 39050 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4751 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1995 | 936 | 0.010 |
Why?
|
| Polymorphism, Genetic | 2 | 1996 | 4328 | 0.010 |
Why?
|
| Hydronephrosis | 1 | 1993 | 269 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2001 | 2948 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2014 | 53288 | 0.010 |
Why?
|
| HLA Antigens | 1 | 1995 | 1381 | 0.010 |
Why?
|
| Disease Models, Animal | 2 | 1999 | 18029 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1995 | 2649 | 0.010 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 3617 | 0.000 |
Why?
|
| Histocytochemistry | 1 | 1989 | 719 | 0.000 |
Why?
|
| Insulin-Like Growth Factor II | 1 | 1989 | 271 | 0.000 |
Why?
|
| Stem Cells | 1 | 2001 | 3567 | 0.000 |
Why?
|
| Plants | 1 | 1988 | 316 | 0.000 |
Why?
|
| Face | 1 | 1993 | 994 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 476 | 0.000 |
Why?
|
| Cross Reactions | 1 | 1988 | 841 | 0.000 |
Why?
|
| Indicators and Reagents | 1 | 1987 | 462 | 0.000 |
Why?
|
| Chickens | 1 | 1987 | 865 | 0.000 |
Why?
|
| Computers | 1 | 1987 | 612 | 0.000 |
Why?
|
| Fishes | 1 | 1987 | 569 | 0.000 |
Why?
|
| DNA, Bacterial | 1 | 1988 | 1465 | 0.000 |
Why?
|
| Transcriptional Activation | 1 | 1989 | 1783 | 0.000 |
Why?
|
| Bone and Bones | 1 | 1993 | 2575 | 0.000 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1989 | 2015 | 0.000 |
Why?
|
| Animals, Newborn | 1 | 1986 | 2726 | 0.000 |
Why?
|
| Gestational Age | 1 | 1989 | 3493 | 0.000 |
Why?
|
| Epitopes | 1 | 1987 | 2571 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2001 | 11524 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1993 | 5985 | 0.000 |
Why?
|
| Models, Biological | 1 | 1995 | 9583 | 0.000 |
Why?
|
| Protein Biosynthesis | 1 | 1986 | 2126 | 0.000 |
Why?
|
| Fetus | 1 | 1986 | 1880 | 0.000 |
Why?
|
| Antibodies | 1 | 1987 | 2460 | 0.000 |
Why?
|
| Aging | 1 | 1986 | 8664 | 0.000 |
Why?
|